Biopharma News
Biopharma news
-
News Regeneron announces an additional $350 million investment and 200 new jobs in Limerick by end-2017
Raheen site will be largest capacity biopharmaceutical production facility in Ireland. -
News Sartorius Stedim Biotech launches Flexsafe 3D Pre-Designed Solutions for storage and shipping applications
New S80 film features consistent cell growth, robustness and high quality. -
News Merck Millipore adds protein pegylation to portfolio of services
Services include feasibility studies, process and analytical development and scale-up. -
News ShangPharma and Qidong Biopharma Industrial Zone sign an agreement for a $60-million investment in China
The plans include a multifunctional preclinical research facility and a state-of-the-art biologics manufacturing facility. -
News Sandoz inaugurates BioInject — a new biopharmaceutical manufacturing facility in Schaftenau, Austria
BioInject is a state-of-the-art facility that will be used to manufacture pre-filled syringes and devices for both Sandoz’s biosimilars and Novartis Pharma’s novel biologics. -
News Horizon Discovery Group enters bioproduction cell line licensing agreement with LakePharma
The terms of the license cover commercial use of a genetically-engineered Chinese Hamster Ovary (CHO) cell line, developed by Horizon and adapted to manufacturing conditions by LakePharma. -
News AstraZeneca purchases US biologics manufacturing facility to support growing pipeline
The LakeCentre facility, located in Boulder, Colorado will increase manufacturing and production capacity to support the company’s extensive portfolio of biologics medicines. -
News SGS Life Sciences Services to host 4th Antwerp Biopharm Seminar on clinical trial solutions
The one-day conference, entitled “Safety and Efficacy — Clinical Trials Solutions”, will bring together experts from SGS Life Services and the wider pharmaceutical industry, to discuss advances in biopharmaceutical research and development and combine ... -
News Aragen Bioscience announces licensing agreement for protein production technology from ProteoNic Biotechnology
Under the terms of the agreement, Aragen gains the rights to apply this technology to the development of recombinant cell lines with significantly enhanced commercial production levels compared to current methods.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance